双歧杆菌脂磷壁酸与5-氟尿嘧啶体内联用对肿瘤细胞凋亡的影响

目的研究双歧杆菌脂磷壁酸与5-氟尿嘧啶联用诱导H22荷瘤小鼠肿瘤细胞凋亡的作用机制。方法双歧杆菌脂磷壁酸联合5-FU处理H22荷瘤Balb/c小鼠,计算抑瘤率,观察小鼠生存期;采用Real time-PCR和Western blot方法分别检测荷瘤小鼠肿瘤组织Bcl-2、Bax和Caspase-3 mRNA及蛋白的表达变化。结果双歧杆菌脂磷壁酸联合5-FU应用,与单独5-FU处理组比较,不仅抑瘤率明显提高（P〈0.01）,且荷瘤小鼠存活时间明显延长（P〈0.01）,肿瘤组织Bcl-2表达下降,Bax和Caspase-3表达升高（P〈0.05）。结论双歧杆菌脂磷壁酸联合5-FU可通过上调Bax和Caspase-3,下调Bcl-2,促进肿瘤细胞凋亡,从而发挥协同抗肿瘤作用。     

双歧杆菌的完整肽聚糖对巨噬细胞产生IL-18的影响

目的探讨分叉双歧杆菌的完整肽聚糖对巨噬细胞功能的调节作用.方法以完整肽聚糖注射于小鼠腹腔,用ELISA法测定小鼠腹腔巨噬细胞产生的IL-18的含量.结果完整肽聚糖注射组小鼠腹腔巨噬细胞产生的IL-18的含量显著高于对照组(P＜0.01).结论分叉双歧杆菌的完整肽聚糖能激活巨噬细胞,并使之分泌多量的IL-18.     

青春双歧杆菌对NOD小鼠1型糖尿病的免疫调节作用

目的 探讨早期应用青春双歧杆菌对NOD小鼠1型糖尿病发病的影响.方法 给予NOD小鼠口服青春双歧杆菌,观察实验组和对照组(PBS)糖尿病发病率,HE染色观察胰岛炎,免疫组化检测胰岛Bcl-2和Bax的表达,RT-PCR测定TNF-α、IFN-γ和IL-10 mRNA表达.结果 实验组胰岛炎程度较对照组明显减轻(P＜0.01),胰岛Bcl-2的表达高于对照组,而Bax的表达低于对照组(P＜0.05);胰腺TNF-α、IFN-γ mRNA表达实验组明显低于对照组(P＜0.05),而IL-10 mRNA表达差异无显著性;实验组发病率低于对照组(P＜0.05).结论 青春双歧杆菌对NOD小鼠1型糖尿病有预防作用,其机制可能与调节Th1/Th2型细胞因子的免疫失衡有关.     

脂磷壁酸的提取工艺及免疫功能的研究

目的确定婴儿双歧杆菌脂磷壁酸（LTA）的最佳提取工艺及其免疫调节作用。方法通过对不同方法提取婴儿双歧杆菌LTA的测定及对植瘤小鼠淋巴细胞的转化来探讨LTA对小鼠细胞免疫的调节作用。结果采用脱脂后水法提取效果最好,与对照组和全菌组相比,LTA使淋巴细胞转化增加。结论婴儿双歧杆菌及其LTA均有免疫功能,但LTA的效果要优于婴儿双歧杆菌。     

双歧杆菌脂磷壁酸与5-氟尿嘧啶联用的抗肿瘤研究

目的探讨双歧杆菌脂磷壁酸与5-氟尿嘧啶（5-Fu）联用对H22荷瘤小鼠的抗肿瘤作用及免疫功能的影响。方法双歧杆菌脂磷壁酸单独或联合5-Fu处理H22荷瘤Balb／c小鼠,定期测量肿瘤大小,观察小鼠一般状况;计算抑瘤率、血红细胞数和白细胞数,取脾和胸腺计算脏器指数;HE染色分析肿瘤组织变化;MTT法检测小鼠脾T淋巴细胞增殖转化功能以及ELISA法检测小鼠脾淋巴细胞分泌IFN-γ含量。结果双歧杆菌脂磷壁酸及5-Fu单独应用均可抑制肿瘤生长,但单独5-Fu处理组小鼠一般状况差,毒性反应重;双歧杆菌脂磷壁酸与5-Fu联合应用,与单独5-Fu处理组比较,不仅抑瘤率明显提高（P〈0．01）,且荷瘤小鼠一般状况改善,白细胞数升高,脏器指数增加,小鼠脾T淋巴细胞增殖能力强,脾淋巴细胞分泌IFN-γ,水平提高;光镜观察HE染色瘤体组织,双歧杆菌脂磷壁酸处理组可见大量炎症细胞浸润。结论双歧杆菌脂磷壁酸联合5-FU能增强化疗的抑瘤作用,并能扭转化疗引起的免疫低下现象,起到增效减毒作用。     

利用文本提取工具构建乳杆菌肽聚糖特异性免疫调节网络

目的探索乳杆菌肽聚糖免疫调节作用的机制。方法BALB／c小鼠腹腔注射乳杆菌肽聚糖,从腹腔巨噬细胞和脾淋巴细胞提取RNA,基因芯片分析基因表达情况,利用Medscan从pubmed文献摘要提取肽聚糖相关基因网络,映射芯片数据获得乳杆菌肽聚糖特异基因网络。结果乳杆菌肽聚糖主要通过TLR2-NF-κB信号通路激活炎性细胞因子的表达,但是PGRP-L可能通过降解肽聚糖对此通路有负调节作用,NF-κB的激活可能诱导NOD2表达,对此通路进行负调节。结论乳杆菌肽聚糖通过与多种受体作用诱导独特的免疫反应,维持机体免疫稳态。     

2001年全年总目次

论著海洋寡糖工程药物——壳寡糖制备分离新工艺及其抗癌活性研究杜昱光 ,张铭俊 ,张虎 ,等 (5 )……………双歧杆菌及其 WPG对 S180 荷瘤小鼠免疫调节和抑瘤作用研究张宝元 ,马晓红 ,刘震 ,等 (8)………………双歧杆菌的完整肽聚糖对实验性大肠癌诱导型一氧化氮合酶表达的影响……………………………………张金浩 ,王立生 ,潘令嘉 ,等 (1 1 )………………………………………………………………………………双歧杆菌对小鼠肝癌腹水瘤细胞 Ca2 - ATPase及糖原磷酸化酶 α的影响任凤 ,王昊人 ,赵宝昌 (1 3 )………双歧杆菌的辐照育种研…     

双歧杆菌及其表面分子的免疫增强作用

研究双歧杆菌及其脂磷壁酸、细胞壁肽聚糖、培养乏液对小鼠腹腔渗出细胞、脾细胞ＩＬ－１、ＩＬ－２、ＩＬ－６、ＴＮＦ、ＩＦＮ－γ活性和脾ＮＫ、ＬＡＫ细胞活性的影响。结果发现双歧杆菌全菌、脂磷壁酸、肽聚糖多次注入小鼠腹腔一段时间后,小鼠脾ＮＫ细胞、ＬＡＫ细胞活性和ＩＦＮ－γ活性增强,腹腔渗出细胞产生ＩＬ－１、ＩＬ－６、ＴＮＦ活性增强,其中以脂磷壁酸作用最强,肽聚糖次之,培养乏液也有一定作用。双歧杆菌及其表面分子对小鼠脾细胞、腹腔渗出细胞ＩＬ－２活性无显著影响。双歧杆菌的免疫增强作用在抗感染、抗肿瘤机理中占有十分重要的地位。     

双歧杆菌的完整肽聚糖对小鼠腹腔巨噬细胞膜脂流动性的影响

目的探讨分叉双歧杆菌的完整肽聚糖（WPG）对巨噬细胞膜脂流动性的影响。方法首先分离培养昆明小鼠腹腔巨噬细胞,然后以WPG刺激巨噬细胞,再用细胞膜磷脂荧光探针标记细胞,最后采用激光共聚焦显微镜结合激光漂白后荧光恢复技术检测巨噬细胞的膜脂流动性。结果WPG刺激组反映小鼠腹腔巨噬细胞膜脂流动性的平均荧光恢复率明显高于对照组（P〈0.01）。结论分叉双歧杆菌的完整肽聚糖可提高巨噬细胞膜脂流动性。     

双歧杆菌的完整肽聚糖对实验性大肠癌凋亡调控基因表达的影响

为探讨双歧杆菌的完整肽聚糖的抑瘤途径及机制,本文以大肠癌裸鼠移植瘤为动物模型,采用免疫组化ＳＰ法检测了４０只裸鼠移植瘤ｂｃｌ－２及ｂａｘ基因的蛋白表达率及表达强度。结果显示完整肽聚糖注射组大肠癌移植瘤ｂｃｌ－２蛋白表达率及阳性细胞密度均低于肿瘤对照组,ｂａｘ基因的表达情况则相反。提示双歧杆菌的完整肽聚糖可使大肠癌裸鼠移植瘤的ｂｃｌ－２基因表达下调,ｂａｘ基因表达增强,最终诱导肿瘤细胞凋亡,实现其抗瘤目的。     

富硒转白细胞介素2基因双歧杆菌对小鼠移植瘤H22的治疗作用

目的评价富硒和转白细胞介素2（IL2）基因双歧杆菌对小鼠移植瘤H22的抑制效果。方法通过电转导将含IL2质粒导入到长双歧杆菌（Bifidobacterium longum,B.longum）中,将转IL2基因双歧杆菌接种到添加了亚硒酸钠（Na2SeO3）的培养基中,利用微生物的富集及转化作用,形成富硒的含IL2基因质粒的双歧杆菌（Se-B.longum-IL2）。结果利用双歧杆菌的肿瘤厌氧区靶向性,通过荷肝癌H22的小鼠尾静脉注射Se-B.longum-IL2,取得了良好的抑瘤效果与荷肝癌小鼠生存延长效果。结论转IL2基因双歧杆菌和富硒联合后对小鼠肝癌有明显的基因治疗前景。     

大肠杆菌-长双歧杆菌穿梭载体的构建及PTEN在长双歧杆菌中的表达

长双歧杆菌可特异地定植于实体瘤低氧区,可用做肿瘤靶向性基因治疗的载体,而构建大肠杆菌-长双歧杆菌穿梭质粒则被证明是外源基因在长双歧杆菌中稳定表达的有效途径。为了构建能在长双歧杆菌中稳定表达外源基因的穿梭质粒并检测携带抑癌基因的工程菌对小鼠实体瘤的抑制效果,利用软件设计并合成了48条部分序列相互重叠的引物,通过PCR合成了长双歧杆菌质粒pMB1序列及长双歧杆菌HU启动子区序列,插入克隆载体pMD18-T,构建穿梭载体pMB-HU,该载体可在大肠杆菌DH5α及长双歧杆菌L17中稳定复制。PTEN基因编码具有蛋白质和酯类双重特异性磷酸酶活性的抑癌因子。将PTEN基因cDNA序列插入载体pMB-HU中HU启动子下游,构建重组质粒pMB-HU-PTEN,电击转化长双歧杆菌后,Western blot检测表明,表达产物中存在55kDa的PTEN蛋白特异条带。抑癌试验表明:与对照组相比,携带PTEN基因的长双歧杆菌可显著抑制小鼠实体瘤的生长。上述结果为以长双歧杆菌为载体的实体瘤靶向性基因治疗研究奠定了基础。     

富硒双歧杆菌缓解5-FU导致的化疗性肠粘膜炎的药效学研究

通过腹腔注射5-FU建立小鼠肠黏膜炎模型,探讨富硒长双歧杆菌(Selenium-enriched Bifidobacterium longum,Se-B.longum)能否改善5-FU所致的小鼠肠黏膜炎。将健康BALB/c小鼠随机分为对照组、5-FU组和Se-B.longum/5-FU组,分别灌胃生理盐水、生理盐水和Se-B.longum(Se0.3 mg/kg BW,1×106bacteria/只)6 d,然后5-FU组和Se-B.longum/5-FU组小鼠均腹腔注射5-FU(250 mg/kg),观察小鼠腹泻及死亡情况,5 d后处死小鼠,计算体重变化、脏器指数及考察肠道组织变化;将健康BALB/c小鼠随机分为对照组、5-FU组和Se-B.longum/5-FU组,分别灌胃生理盐水、生理盐水和Se-B.longum(Se 0.3 mg/kg BW,1×106bacteria/只)6 d,然后5-FU组和Se-B.longum/5-FU组小鼠均腹腔注射5-FU(300 mg/kg),观察小鼠死亡情况,绘制生存曲线。Se-B.longum能缓解5-FU导致的正常小鼠的肠粘膜炎、降低小鼠死亡率。     

Inhibitory effect of apple pectin and culture condensate of Bifidobacterium longum on colorectal tumors induced by 1,2-dimethylhydrazine in transgenic mice harboring human prototype c-Ha-ras genes.

The number and tumor score of colorectal tumors induced by 1,2-dymethylhydrazine in transgenic (Tg) mice carrying human c-Ha-ras genes were significantly reduced by ingestion of apple pectin (AP) or a culture condensate of Bifidobacterium longum (MB) when compared with a control diet. There was no statistical difference in the incidence of colorectal tumors in Tg mice between the AP or MB diet and the control diet. This study demonstrated that Tg mice are a useful tool for screening inhibition of colorectal tumors by functional foods.     

Production and characterization of anti-bifidobacteria monoclonal antibodies and their application in the development of an immuno-culture detection method

An immuno-culture method has been developed by combination of specific monoclonal antibodies and plate culture to allow detection of viable bifidobacteria. Cell wall proteins were selected as surface antigen to produce antibodies against bifidobacteria. The cell wall proteins were extracted and purified from six ATCC strains of bifidobacteria grown in MRS broth using an anaerobic system. To compare the profile of the protein extracts, all the protein solutions obtained were analyzed by SDS-PAGE. Similar bands corresponding to the major proteins of each species of bifidobacteria were observed. The proteins were tested for their immunogenicity in Balb/c mice after immunization and subsequent analysis using ELISA procedures. High immune responses were generated in mice immunized by proteins from Bifidobacterium bifidum and Bifidobacterium longum. Monoclonal antibodies were produced against B. longum and tested for their specificity, sensitivity and cross reactivity with other bifidobacteria species. All the hybridoma cells selected produced anti-B. longum antibodies cross-reacting with native and purified proteins from five other bifidobacteria species. An epitope supported by a cross-reacting protein of 58 kDa shared by bifidobacteria was revealed by western blot. This was confirmed by immune-transmission electron microscopy observations which showed the specific interaction of these antibodies with bifidobacterial cell wall proteins. Also, the antibody obtained was found to be specific for the genus Bifidobacterium and sensitive, allowing the detection of at least 10(5) target cells/ml. An immuno-culture detection approach was then developed using the selected anti-B. longum antibodies. This method was shown to be very efficient for the detection of viable cells of bifidobacteria suggesting the possibility of its use to quantify these bacteria in various food matrices.     

Bifidobacterium microbiota and parameters of immune function in elderly subjects

Faecal and serum samples were collected over a period of 6 months from 55 institutionalized elderly subjects, who were enrolled in a double-blind placebo-controlled study. Participants were randomized in one of the three treatment groups: intervention (two probiotic Bifidobacterium longum strains: 2C and 46), placebo and commercial control (Bifidobacterium lactis Bb-12). The faecal Bifidobacterium microbiota was characterized by genus and species-specific PCR. Serum levels of the cytokines IL-10, tumor necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta1 were determined by enzyme-linked immunosorbent assay. Each participant harboured on average approximately three different bifidobacterial species. The most frequently detected species were B. longum, Bifidobacterium adolescentis and Bifidobacterium bifidum. Depending on the treatment, the intervention resulted in specific changes in the levels of certain Bifidobacterium species, and positive correlations were found between the different species. Negative correlations were observed between the levels of Bifidobacterium species and the pro-inflammatory cytokine TNF-alpha and the regulatory cytokine IL-10. The presence of faecal B. longum and Bifidobacterium animalis correlated with reduced serum IL-10. The anti-inflammatory TGF-beta1 levels were increased over time in all three groups, and the presence of Bifidobacterium breve correlated with higher serum TGF-beta1 levels. This indicates that modulation of the faecal Bifidobacterium microbiota may provide a means of influencing inflammatory responses.     

Evaluation of the PCR method for identification of Bifidobacterium species

AIMS: Bifidobacterium species are known for their beneficial effects on health and their wide use as probiotics. Although various polymerase chain reaction (PCR) methods for the identification of Bifidobacterium species have been published, the reliability of these methods remains open to question. METHODS AND RESULTS: In this study, we evaluated 37 previously reported PCR primer sets designed to amplify 16S rDNA, 23S rDNA, intergenic spacer regions, or repetitive DNA sequences of various Bifidobacterium species. CONCLUSIONS: Ten of 37 experimental primer sets showed specificity for B. adolescentis, B. angulatum, B. pseudocatenulatum, B. breve, B. bifidum, B. longum, B. longum biovar infantis and B. dentium. SIGNIFICANCE AND IMPACT OF THE STUDY: The results suggest that published Bifidobacterium primer sets should be re-evaluated for both reproducibility and specificity for the identification of Bifidobacterium species using PCR. Improvement of existing PCR methods will be needed to facilitate identification of other Bifidobacterium strains, such as B. animalis, B. catenulatum, B. thermophilum and B. subtile.     

Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V,Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536

The consumption of probiotic-based products has risen greatly in recent decades. Due to their probiotic characteristics, microorganisms such as lactobacilli and bifidobacteria are in daily use in the production of food supplements. In the present study, three bifidobacterial strains (Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536) were tested for growth compatibility, resistance to antimicrobial agents, antibacterial activity against pathogens, resistance to gastric acidity, bile salt hydrolysis and adhesion to the human intestinal epithelial cell line HT29. All of these strains were resistant to gentamycin, but none showed in vitro growth incompatibility or the presence of known resistance determinants. B. breve M-16 V had the best probiotic characteristics and, indeed, was the only strain possessing antibacterial activity against Escherichia coli and Klebsiella pneumoniae. All strains were resistant to simulated gastric juice, while only B. longum subsp. longum BB536 and B. breve M-16 V showed a bile salt hydrolytic activity. Interestingly, a strong adhesion to HT29 cells was observed in all Bifidobacterium strains. In conclusion, B. breve M-16 V, B. longum subsp. longum BB536 and B. longum subsp. infantis M-63 showed several promising characteristics as probiotic strains.     

Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria

The bifidogenic effect of human milk oligosaccharides (HMOs) has long been known, yet the precise mechanism underlying it remains unresolved. Recent studies show that some species/subspecies of Bifidobacterium are equipped with genetic and enzymatic sets dedicated to the utilization of HMOs, and consequently they can grow on HMOs; however, the ability to metabolize HMOs has not been directly linked to the actual metabolic behavior of the bacteria. In this report, we clarify the fate of each HMO during cultivation of infant gut-associated bifidobacteria. Bifidobacterium bifidum JCM1254, Bifidobacterium longum subsp. infantis JCM1222, Bifidobacterium longum subsp. longum JCM1217, and Bifidobacterium breve JCM1192 were selected for this purpose and were grown on HMO media containing a main neutral oligosaccharide fraction. The mono- and oligosaccharides in the spent media were labeled with 2-anthranilic acid, and their concentrations were determined at various incubation times using normal phase high performance liquid chromatography. The results reflect the metabolic abilities of the respective bifidobacteria. B. bifidum used secretory glycosidases to degrade HMOs, whereas B. longum subsp. infantis assimilated all HMOs by incorporating them in their intact forms. B. longum subsp. longum and B. breve consumed lacto-N-tetraose only. Interestingly, B. bifidum left degraded HMO metabolites outside of the cell even when the cells initiate vegetative growth, which indicates that the different species/subspecies can share the produced sugars. The predominance of type 1 chains in HMOs and the preferential use of type 1 HMO by infant gut-associated bifidobacteria suggest the coevolution of the bacteria with humans.     

Structural studies of cell wall polysaccharides from Bifidobacterium breve YIT 4010 and related Bifidobacterium species

The chemical compositions of the cell walls obtained from 8 strains in 5 species of Bifidobacterium were analyzed. These cell walls were shown to be composed of peptidoglycan and polysaccharide moieties. Some variations with respect to contents of neutral sugars and content of phosphorus were observed with some cell wall preparations from the same species. The neutral polysaccharides in cell walls of 4 strains of Bifidobacterium (B. bifidum YIT 4007, B. breve YIT 4010, B. infantis YIT 4025, and B. longum ATCC 15707) were purified and their chemical structures were analyzed. One of these polysaccharides, obtained from B. breve YIT 4010, was analyzed in detail by GLC, 1H- and 13C-NMR spectroscopic analyses, methylation, Smith degradation and acetolysis, and the results suggested the following structure for the repeating unit of the polysaccharide: (Formula: see text).